Development of a method for better estimation of warfarin dose in patients requiring warfarin therapy
Not Applicable
Completed
- Conditions
- Health Condition 1: null- atrial fibrillation and valve replacement patients requiring chronic anticoagulation therapy
- Registration Number
- CTRI/2018/06/014614
- Lead Sponsor
- Dr Nusrat Shafiq
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 82
Inclusion Criteria
Adult patients of atrial fibrillation and patients requiring valve replacement surgeries on chronic anticoagulation therapy with warfarin
Exclusion Criteria
1. Patients with known contraindications to anticoagulant therapy,
2. Patients of transient atrial fibrillation secondary to reversible disorders such as thyrotoxicosis, cardiothoracic surgery and severe anaemia,
3. Patients with underlying hepatic (defined as elevation in alanine/ aspartate transaminase >2.5 times the upper limit of normal) and or severe renal insufficiency(defined as creatinine clearance of <30ml/min),
4. Pregnant and nursing women,
5. Patients unwilling to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method